TERUMO CORPORATION, ASHITAKA CAPIOX FX25 OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS
|
Back to Search Results |
|
Model Number N/A |
Device Problem
Infusion or Flow Problem (2964)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 07/18/2022 |
Event Type
Injury
|
Event Description
|
The user facility reported there were issues with the involved capiox fx15 device during priming.There was a latency in the passage of priming the cardiotomy filter.Therefore, the user decided to replace the device.The final patient impact was not harmed.The event occurred pre-treatment.
|
|
Manufacturer Narrative
|
Initial reporter occupation: perfusionist.Pma/510(k)- k130520.The actual device has not been returned for evaluation.The investigation is currently ongoing.A follow-up report will be submitted once the investigation is complete.Review of the manufacturing record and the shipping inspection record of the actual product confirmed that there were not any indications of anomaly in them.A search of the complaint file found no other similar report with the involved product code/lot number combination.Terumo medical products (tmp) (importer) registration no.(b)(4) is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.(b)(4).
|
|
Manufacturer Narrative
|
Visual inspection of the actual sample did not find any anomaly such as a breakage.After rinsing and drying the actual sample, for the actual reservoir, the pressure drop when flowing in bovine blood (hct: 35%, temp.: 37°c) at a flow rate of 5l/min was measured.It was confirmed to meet the factory's specifications and no obstruction was found.The actual oxygenator was installed into a circuit consisting of tubes, and the pressure drop when circulating bovine blood (hct: 35%, temp.: 37°c) at a flow rate of 5l/min was measured.It was confirmed to meet the factory's specifications and no obstruction was found.Saline solution was flowed in the blood channel.No blood clot that led to the obstruction was formed.Review of the manufacturing record and the shipping inspection record of the actual sample confirmed that there was not any anomaly in them.A search of the complaint file found no other similar report with the involved product code/lot number combination.Based on the investigation result, no anomaly was found in the actual sample after rinsing.As a cause of occurrence, it was likely that blood-derived obstructing occurred for some reason.However, since there was no anomaly in the performance test of actual sample, it was not possible to clarify the cause of this complaint from the investigation result.
|
|
Event Description
|
Additional information was received on 19 sep 2022: it was confirmed that the oxygenator was not used for the cec; however, there was blood inside due to recirculating with the cannulated patient.When the issue was noticed, there was no time to stop the surgeon from aspirating blood from the operating field with the aspirator connected to the cardiotome.The blood was not infected and was heparinized.The device was replaced after the blood was circulating, including the aspirated blood, therefore this case was a serious injury.The event occurred intra-operative.There was no patient injury/medical or surgical intervention required.
|
|
Search Alerts/Recalls
|
|
|